MVM is a growth equity investor that invests broadly across the healthcare sector, including in specialty pharmaceuticals, medical technology, diagnostics, life science tools, consumer healthcare, veterinary medicine, healthcare services, and healthcare IT.
MVM focuses on the risk and return characteristics of an investment opportunity rather than the traditional criteria used to define healthcare investments. As such, we are not prescriptive with respect to sub-sector or therapeutic category.
MVM does not have fixed criteria for investment size but we expect to make aggregate investments of $10 to 30 million in each of our portfolio companies over the lifetime of our holdings in the company.
MVM has the flexibility to invest in any investment security, including those of listed companies as well as debt instruments and MVM will consider investing in companies based anywhere in the world.